$LCID
Lucid Group, Inc. Stock $lcid

$lcid Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000162828022028925 Filed on November 08, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$257.7M	$195.5M
YoY Change	876.48%	84148.71%
Cost Of Revenue	$615.3M	$492.5M
YoY Change	306.21%	14733.83%
Gross Profit	-$357.6M	-$297.0M
YoY Change	185.88%	9518.72%
Gross Profit Margin	-138.75%	-151.96%
Selling, General & Admin	$170.9M	$176.7M
YoY Change	-13.26%	-29.74%
% of Gross Profit
Research & Development	$221.3M	$213.8M
YoY Change	35.26%	-11.82%
% of Gross Profit
Depreciation & Amortization	$55.24M	$50.65M
YoY Change	52.24%	239.95%
% of Gross Profit
Operating Expenses	$392.2M	$390.5M
YoY Change	8.75%	-20.95%
Operating Profit	-$749.7M	-$687.5M
YoY Change	54.37%	38.32%
Interest Expense	$21.40M	$7.613M
YoY Change	-1794.14%	9917.11%
% of Operating Profit
Other Income/Expense, Net	$255.5M	$157.6M
YoY Change	-145.74%	-676.53%
Pretax Income	-$472.8M	-$530.0M
YoY Change	-54.78%	1.06%
Income Tax	-$161.0K	$100.0K
% Of Pretax Income
Net Earnings	-$472.6M	-$530.1M
YoY Change	-54.8%	1.09%
Net Earnings / Revenue	-183.4%	-271.21%
Basic Earnings Per Share		-$0.32
Diluted Earnings Per Share	-$0.28	-$0.40
COMMON SHARES
Basic Shares Outstanding	1.680B shares	1.673B shares
Diluted Shares Outstanding		1.691B shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.913B	$3.342B
YoY Change	-37.52%	-30.33%
Cash & Equivalents	$1.736B	$1.264B
Short-Term Investments	$2.177B	$2.078B
Other Short-Term Assets	$81.54M	$69.01M
YoY Change	88.19%	241.4%
Inventory	$834.4M	$685.3M
Prepaid Expenses	$63.55M	$57.26M
Receivables	$19.54M	$2.659M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.912B	$4.156B
YoY Change	-24.51%	-16.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.382B	$2.166B
YoY Change	77.21%	124.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$530.0M	$513.7M
YoY Change
Other Assets	$55.30M	$51.49M
YoY Change	80.67%	20.59%
Total Long-Term Assets	$2.967B	$2.731B
YoY Change	115.84%	137.02%
TOTAL ASSETS
Total Short-Term Assets	$4.912B	$4.156B
Total Long-Term Assets	$2.967B	$2.731B
Total Assets	$7.879B	$6.888B
YoY Change	-0.03%	12.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$229.1M	$79.78M
YoY Change	454.12%	795.01%
Accrued Expenses	$63.32M	$56.82M
YoY Change	45.84%	30.45%
Deferred Revenue
YoY Change
Short-Term Debt	$9.595M	$13.58M
YoY Change	-37.21%	-44.98%
Long-Term Debt Due	$10.59M	$9.780M
YoY Change	153.07%	199.27%
Total Short-Term Liabilities	$937.6M	$825.1M
YoY Change	136.7%	206.27%
LONG-TERM LIABILITIES
Long-Term Debt	$1.992B	$1.991B
YoY Change	0.25%	42370.04%
Other Long-Term Liabilities	$378.2M	$365.0M
YoY Change	100.56%	99.35%
Total Long-Term Liabilities	$2.370B	$2.356B
YoY Change	8.95%	1186.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$937.6M	$825.1M
Total Long-Term Liabilities	$2.370B	$2.356B
Total Liabilities	$3.530B	$3.657B
YoY Change	-11.15%	182.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.400B	-$6.900B
YoY Change	21.99%	38.0%
Common Stock	$183.0K	$168.0K
YoY Change	10.91%	2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.350B	$3.231B
YoY Change
Total Liabilities & Shareholders Equity	$7.879B	$6.888B
YoY Change	-0.03%	12.19%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$472.6M	-$530.1M
YoY Change	-54.8%	1.09%
Depreciation, Depletion And Amortization	$55.24M	$50.65M
YoY Change	52.24%	239.95%
Cash From Operating Activities	-$648.5M	-$569.5M
YoY Change	107.37%	95.29%
INVESTING ACTIVITIES
Capital Expenditures	$289.9M	-$290.1M
YoY Change	-337.79%	212.64%
Acquisitions
YoY Change
Other Investing Activities	-$102.8M	-$1.085B
YoY Change	-20329.92%
Cash From Investing Activities	-$392.7M	-$1.375B
YoY Change	223.44%	1381.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.513B	17.64M
YoY Change	-20.36%	-99.62%
NET CHANGE
Cash From Operating Activities	-648.5M	-569.5M
Cash From Investing Activities	-392.7M	-1.375B
Cash From Financing Activities	1.513B	17.64M
Net Change In Cash	471.6M	-1.927B
YoY Change	-67.82%	-145.44%
FREE CASH FLOW
Cash From Operating Activities	-$648.5M	-$569.5M
Capital Expenditures	$289.9M	-$290.1M
Free Cash Flow	-$938.4M	-$279.4M
YoY Change	391.76%	40.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001811210
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39408
	dei	Entity Registrant Name EntityRegistrantName	Lucid Group, Inc.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0891392
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7373 Gateway Boulevard
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94560
	dei	City Area Code CityAreaCode	510
	dei	Local Phone Number LocalPhoneNumber	648-3553
	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	LCID
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1680431090	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1264136000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6262905000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	2078045000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2659000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3148000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	685321000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	57259000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	70346000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	69008000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43328000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	4156428000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6506977000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1954310000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	211844000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	usd
CY2022Q3	us-gaap	Long Term Investments LongTermInvestments	513735000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51494000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30609000	usd
CY2022Q3	us-gaap	Assets Assets	6887811000	usd
CY2021Q4	us-gaap	Assets Assets	7881713000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	79781000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41342000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49008000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32364000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9780000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	686555000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	825124000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	396101000	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	79371000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	usd
CY2022Q3	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	396489000	usd
CY2021Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	1394808000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1990571000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1986791000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	365009000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3656564000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3972358000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1681005163	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1648413415	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1680147338	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1647555590	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	168000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	165000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10162745000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9995778000	usd
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	857825	shares
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	857825	shares
CY2022Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20716000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20716000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13266000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6897684000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6065872000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3231247000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6887811000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7881713000	usd
CY2022Q3	us-gaap	Revenues Revenues	195457000	usd
CY2021Q3	us-gaap	Revenues Revenues	232000	usd
	us-gaap	Revenues Revenues	350468000	usd
	us-gaap	Revenues Revenues	719000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	492483000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	3320000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1030795000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3424000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	213761000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	242408000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	600218000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	586579000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	176736000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	251554000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	563707000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	455478000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	882980000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	497282000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	2194720000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1045481000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-687523000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-497050000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1844252000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1044762000	usd
CY2022Q3	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
CY2021Q3	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454546000	usd
CY2022Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	0	usd
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2717000	usd
	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	0	usd
	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2717000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	24373000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	27284000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	7613000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	76000	usd
	us-gaap	Interest Expense InterestExpense	22521000	usd
	us-gaap	Interest Expense InterestExpense	111000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	665000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	249000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9898000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-151000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	157571000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27331000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1012980000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-489288000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-529952000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-524381000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-831272000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1534050000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	149000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	540000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-530101000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-524403000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-831812000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1534081000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-530101000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-524403000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-831812000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3701413000	usd
CY2022Q3	us-gaap	Dilutive Securities DilutiveSecurities	-140146000	usd
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	-998319000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-670247000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-524403000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1830131000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3701413000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1676048504	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1217032285	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1666693217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	432654607	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1690963548	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1217032285	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1686576589	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	432654607	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.56
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.56
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-12575000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-13266000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-542676000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-524403000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-845078000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1534081000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-542676000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-524403000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-845078000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3701413000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3710386000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-530101000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-12575000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	21654000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1889000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	83302000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3231247000	usd
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1155909367	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5836785000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-4469172000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-524403000	usd
CY2021Q3	lcid	Temporary Equity Conversion Of Preferred Stock Into Common Stock Shares TemporaryEquityConversionOfPreferredStockIntoCommonStockShares	1155909367	shares
CY2021Q3	lcid	Temporary Equity Conversion Of Preferred Stock Into Common Stock Value TemporaryEquityConversionOfPreferredStockIntoCommonStockValue	5836785000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5836785000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3590956000	usd
CY2021Q3	lcid	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	173273000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	763000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	236956000	usd
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	4845158000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-831812000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-13266000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	212895000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12882000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14738000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	352245000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3231247000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1318777000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1534081000	usd
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2151613000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	14254000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	8629000	usd
	lcid	Temporary Equity Conversion Of Preferred Stock Into Common Stock Shares TemporaryEquityConversionOfPreferredStockIntoCommonStockShares	1155909367	shares
	lcid	Temporary Equity Conversion Of Preferred Stock Into Common Stock Value TemporaryEquityConversionOfPreferredStockIntoCommonStockValue	5836785000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5836785000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3590956000	usd
	lcid	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	173273000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6029000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	242586000	usd
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	4845158000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-831812000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1534081000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	131343000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	26621000	usd
	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	25188000	usd
	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	7184000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	352245000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	366200000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	364553000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	0	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-454546000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5020000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-56000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-489000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	906054000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60112000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	12101000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	65697000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	33262000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-8299000	usd
	lcid	Proceeds From Government Grant ProceedsFromGovernmentGrant	97267000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	39082000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5861000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	52216000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14175000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16644000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	12752000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10761000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4516000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	281545000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	17834000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	20191000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	5158000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1577743000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-745401000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	784964000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	299313000	usd
	lcid	Proceeds From Government Grant ProceedsFromGovernmentGrant	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	19000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2726677000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	125353000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3289021000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-299294000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15330000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	16819000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3605000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1915000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	41935000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20228000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	6653000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	31700000	usd
	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14738000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6027000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173273000	usd
	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439153000	usd
	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	0	usd
	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	4811000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	12882000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	212895000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6631000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-165566000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5236843000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5032330000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4192148000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1265690000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4832566000	usd
	us-gaap	Interest Paid Net InterestPaidNet	11307000	usd
	us-gaap	Interest Paid Net InterestPaidNet	324000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	480000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	65267000	usd
	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	5756000	usd
	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	143972000	usd
	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	70756000	usd
	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	usd
	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	9936000	usd
	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	0	usd
	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	2167332000	usd
	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	0	usd
	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	15719000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	5836785000	usd
	lcid	Transaction Costs Related To The Reverse Recapitalization Not Yet Paid TransactionCostsRelatedToTheReverseRecapitalizationNotYetPaid	0	usd
	lcid	Transaction Costs Related To The Reverse Recapitalization Not Yet Paid TransactionCostsRelatedToTheReverseRecapitalizationNotYetPaid	34054000	usd
	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid Group, Inc. (“Lucid”) is a technology and automotive company focused on designing, developing, manufacturing, and selling the next generation of EV, EV powertrains and battery systems.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid was originally incorporated in Delaware on April 30, 2020 under the name Churchill Capital Corp IV (formerly known as Annetta Acquisition Corp) (“Churchill”) as a special purpose acquisition company with the purpose of effecting a merger with one or more operating businesses. On February 22, 2021, Churchill entered into a definitive merger agreement (the “Merger Agreement”) with Atieva, Inc. (“Legacy Lucid”) in which Legacy Lucid would become a wholly owned subsidiary of Churchill (the “Merger”). Upon the closing of the Merger on July 23, 2021 (the “Closing”), Churchill was immediately renamed to “Lucid Group, Inc.” The Merger between Churchill and Legacy Lucid was accounted for as a reverse recapitalization. See Note 3 “Reverse Recapitalization” for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the notes to the condensed consolidated financial statements, unless otherwise noted, the “Company,” “we,” “us” or “our” and similar terms refer to Legacy Lucid and its subsidiaries prior to the consummation of the Merger, and Lucid and its subsidiaries after the consummation of the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company devotes its efforts to business planning, research and development, recruiting of management and technical staff, acquiring operating assets, and raising capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through September 30, 2022, the Company has incurred operating losses and negative cash flows from operating activities. For the nine months ended September 30, 2022 and 2021, the Company has incurred operating losses, including net losses of $831.8 million and $1.5 billion, respectively. The Company has an accumulated deficit of $6.9 billion as of September 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2021, the Company completed the first phase of the construction of its Advanced Manufacturing Plant 1 in Casa Grande, Arizona (“AMP-1”). The Company began commercial production of its first vehicle, the Lucid Air, in September 2021 and delivered its first vehicles in late October 2021. The Company continues to expand AMP-1, construct its planned Advanced Manufacturing Plant 2 in the Kingdom of Saudi Arabia (“AMP-2”), and build a network of retail sales and service locations. The Company has plans for continued development of additional vehicle model types for future release. The aforementioned activities will require considerable capital, above and beyond the expected cash inflows from the initial sales of the Lucid Air. As such, the future operating plan involves considerable risk if secure funding sources are not identified and confirmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s existing sources of liquidity include cash, cash equivalents and investments. Historically, the Company funded operations primarily with issuances of convertible preferred stock and convertible notes. Upon the completion of the Merger, the Company received $4,400.3 million in cash proceeds, net of transaction costs. In December 2021, the Company issued an aggregate of $2,012.5 million principal amount of 1.25% convertible senior notes due in December 2026. In addition, during the nine months ended September 30, 2022, the Company entered into a loan agreement with the Saudi Industrial Development Fund (“SIDF”) with an aggregate principal amount of up to approximately $1.4 billion, revolving credit facilities with Gulf International Bank (“GIB”) in an aggregate principal amount of approximately $266.2 million and a new five-year senior secured asset-based revolving credit facility (“ABL Credit Facility”) with an initial aggregate principal commitment amount of up to $1.0 billion. See Note 6 “Debt” for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s current business activities consist of (i) generating sales from the deliveries and service of vehicles, (ii) research and development efforts to design, engineer and develop high-performance fully electric vehicles and advanced electric vehicle powertrain components, including battery pack systems, (iii) production and manufacturing ramps at existing manufacturing facilities in Casa Grande, Arizona, (iv) phase 2 of construction at AMP-1 in Casa Grande, Arizona, (v) the construction of AMP-2, and (vi) expansion of its retail studios and service centers capabilities throughout North America and across the globe. The Company is subject to the risks associated with such activities, including the need to further develop its technology, its marketing, and distribution channels; further develop its supply chain and manufacturing; and hire additional management and other key personnel. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including our ability to access potential markets, and secure long-term financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participates in a dynamic high-technology industry. Changes in any of the following areas could have a material adverse impact on the Company’s future financial position, results of operations, and/or cash flows: advances and trends in new technologies; competitive pressures; changes in the overall demand for its products and services; acceptance of the Company’s products and services; litigation or claims against the Company based on intellectual property (including patents), regulatory, or other factors; and the Company’s ability to attract and retain employees necessary to support its growth.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A global economic recession or other downturn, whether due to inflation, ongoing conflict in Ukraine or other geopolitical events, COVID-19 or other public health crises, interest rate increases or other policy actions by major central banks, or other factors, may have an adverse impact on the Company’s business, prospects, financial condition and results of operations. Adverse economic conditions as well as uncertainty about the current and future global economic conditions may cause the Company’s customers to defer purchases or cancel their reservations and orders in response to tighter credit, decreased cash availability, fluctuations in foreign currency exchange rates, and weakened consumer confidence. Reduced demand for the Company’s products may result in significant decreases in product sales, which in turn would have a material adverse impact on the Company’s business, prospects, financial condition and results of operations. Because of the Company’s premium brand positioning and pricing, an economic downturn is likely to have a heightened adverse effect on the Company compared to many of its electric vehicle and traditional automotive industry competitors, to the extent that consumer demand for luxury goods is reduced in favor of lower-priced alternatives. In addition, any economic recession or other downturn could also cause logistical challenges and other operational risks if any of the Company’s suppliers, sub-suppliers or partners become insolvent or are otherwise unable to continue their operations, fulfill their obligations to the Company, or meet the Company’s future demand. In addition, the deterioration of conditions in global credit markets may limit the Company’s ability to obtain external financing to fund its operations and capital expenditures on terms favorable to the Company, if at all. See “Risk Factors” in Part II, Item 1A of this </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Form 10-Q (the “Quarterly Report”) for additional information regarding risks associated with a global economic recession, including under the caption “</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A global economic recession or other downturn may have a material adverse impact on our business, prospects, results of operations and financial condition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact the global economy and cause significant macroeconomic uncertainty. Infection rates vary across the jurisdictions in which the Company operates. Governmental authorities have continued to implement numerous and constantly evolving measures to attempt to contain the virus, such as travel bans and restrictions, masking recommendations and mandates, vaccine recommendations and mandates, limits on gatherings, quarantines, shelter-in-place orders and business shutdowns. The Company has taken proactive action to protect the health and safety of its employees, customers, partners and suppliers, consistent with the latest and evolving governmental guidelines. Until the COVID-19 pandemic is adequately contained, the Company expects to continue to implement appropriate measures. The Company continues to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations and requirements or as the Company otherwise sees fit to protect the health and safety of its employees, customers, partners and suppliers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While certain of the Company and its suppliers’ operations have from time-to-time been temporarily affected by government-mandated restrictions, the Company was able to commence and continue deliveries of the Lucid Air to customers and to proceed with the construction of AMP-1 and AMP-2. Broader impacts of the pandemic have included inflationary pressure as well as ongoing, industry-wide challenges in logistics and supply chains, such as increased port congestion, intermittent supplier delays and a shortfall of semiconductor supply. Because the Company relies on third party suppliers for the development, manufacture, and/or provision and development of many of the key components and materials used in its vehicles, as well as provisioning and servicing equipment in its manufacturing facilities, the Company has been affected by inflation and such industry-wide challenges in logistics and supply chains. While the Company continues to focus on mitigating risks to its operations and supply chain in the current industry environment, the Company expects that these industry-wide trends will continue to impact its cost structure as well as its ability and the ability of its suppliers to obtain parts, components and manufacturing equipment on a timely basis for the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current circumstances, given the dynamic nature of the situation, any impact on the Company’s financial condition, results of operations or cash flows in the future continues to be difficult to estimate and predict, as it depends on future events that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the outbreak, its severity, potential additional waves of infection, the emergence of more virulent or more dangerous strains of the virus, the actions taken to mitigate the virus or its impact, the development, distribution, efficacy and acceptance of vaccines worldwide, how quickly and to what extent normal economic and operating conditions can resume, the broader impact that the pandemic is having on the economy and our industry and specific implications the pandemic may have on the Company’s suppliers and on global logistics. See “Risk Factors” in Part II, Item 1A of this </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information regarding risks associated with the COVID-19 pandemic, including under the caption “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic has adversely affected, and we cannot predict its ultimate impact on, our business, prospects, results of operations and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”</span></div>
	us-gaap	Net Income Loss NetIncomeLoss	-831800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1500000000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6900000000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates, assumptions and judgments made by management include, among others, inventory valuation, warranty reserve, the determination of the useful lives of property, plant and equipment, fair value of preferred stock warrants, fair value of common stock warrants, fair value of contingent forward contracts liability, estimates of residual value guarantee (“RVG”), valuation of deferred income tax assets and uncertain tax positions, fair value of common stock and other assumptions used to measure stock-based compensation expense, and estimated incremental borrowing rates for assessing operating and financing leases. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period balances have been reclassified to conform to the current period presentation in the condensed consolidated financial statements and the accompanying notes.</span></div>
CY2022Q3	us-gaap	Cash Cash	1264136000	usd
CY2021Q4	us-gaap	Cash Cash	6262905000	usd
CY2021Q3	us-gaap	Cash Cash	4796880000	usd
CY2020Q4	us-gaap	Cash Cash	614412000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1554000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10740000	usd
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	10970000	usd
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11278000	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	24375000	usd
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	24716000	usd
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14728000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1265690000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4832566000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, and investments. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits, but at times its deposits may exceed federally insured limits.</span></div>
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Vehicle Sales with Residual Value Guarantee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides an RVG to its commercial banking partner in connection with its vehicle leasing program. Under the vehicle leasing program, the Company generally receives full payment for the vehicle sales price at the time of delivery, does not bear casualty and credit risks during the lease term, and is contractually obligated (or entitled) to share a portion of the shortfall (or excess) between the resale value realized by the commercial banking partner and a predetermined resale value. During the three and nine months ended September 30, 2022, vehicle sales with RVG totaled $10.1 million. At the lease inception, the Company is required to deposit cash collateral equal to a contractual percentage of the residual value of the leased vehicles with the commercial banking partner. The cash collateral is held in a restricted bank account owned by the commercial banking partner until it is used, as applicable, in settlement of the RVG at the end of the lease term. Cash collateral is recorded in other long-term assets, subject to asset impairment review at each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the vehicle leasing program in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 460, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is the lessor at inception of a lease and immediately transfers the lease as well as the underlying vehicle to its commercial banking partner, with the transaction being accounted for as a sale under ASC 606. The Company recognizes revenue when control transfers upon delivery when the consumer-lessee takes physical possession of the vehicle, and bifurcates the RVG at fair value and accounts for it as a guarantee liability. The remaining amount of the transaction price is allocated among the performance obligations, including the vehicle, the unspecified over-the-air (“</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTA”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> software updates and remarketing activities, in proportion to the standalone selling price of the Company’s performance obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guarantee liability represents the estimated amount the Company expects to pay at the end of the lease term. The Company is released from residual risk upon either expiration or settlement of the RVG. The Company evaluates variables such as third-party residual value publications, risk of future price deterioration due to changes in market conditions and reconditioning costs to determine the estimated residual value guarantee liability. As we accumulate more data related to the resale value of our vehicles or as market conditions change, there could be material changes to the estimated guarantee liabilities. As of September 30, 2022, the RVG liability was immaterial.</span></div>
CY2022Q3	lcid	Revenue Of Vehicle Sales With Residual Value Guarantee RevenueOfVehicleSalesWithResidualValueGuarantee	10100000	usd
	lcid	Revenue Of Vehicle Sales With Residual Value Guarantee RevenueOfVehicleSalesWithResidualValueGuarantee	10100000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	16418321	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439200000	usd
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	2.644
CY2021Q3	lcid	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments And Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsAndOptionsOutstandingNumber	42182931	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	437182072	shares
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	437182072	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25764610	shares
CY2021Q3	lcid	Share Based Payment Award Options Converted ShareBasedPaymentAwardOptionsConverted	68121210	shares
CY2021Q3	lcid	Share Based Payment Award Non Option Equity Instruments Converted Reverse Recapitalization ShareBasedPaymentAwardNonOptionEquityInstrumentsConvertedReverseRecapitalization	43409870	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	usd
CY2021Q3	lcid	Reverse Recapitalization Working Capital Loan Converted Amount ReverseRecapitalizationWorkingCapitalLoanConvertedAmount	1500000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1500000	shares
CY2021Q3	lcid	Debt Conversion Converted Instrument Warrants Or Options Issued Price Per Warrant DebtConversionConvertedInstrumentWarrantsOrOptionsIssuedPricePerWarrant	1.00
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares ReverseRecapitalizationContingentConsiderationShares	17250000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	lcid	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	1193226511	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	85750000	shares
CY2021Q3	lcid	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	2070100000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	usd
CY2021Q3	us-gaap	Cash Cash	400000	usd
CY2021Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200000	usd
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	21644	shares
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Incurred ReverseRecapitalizationTransactionCostsIncurred	38900000	usd
CY2021Q3	lcid	Adjustments To Additional Paid In Capital Reduction For Reverse Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalReductionForReverseRecapitalizationTransactionCosts	36200000	usd
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2700000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	464854000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	87646000	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	49375000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	30641000	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	171092000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8963000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	685321000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	186500000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	364600000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	2171720000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1268166000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	217410000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	86013000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1954310000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	usd
CY2022Q3	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	50600000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	131300000	usd
CY2021Q3	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	14900000	usd
	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	26600000	usd
CY2022Q3	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	26925000	usd
CY2021Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	33950000	usd
CY2022Q3	us-gaap	Construction Payable Current ConstructionPayableCurrent	213551000	usd
CY2021Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	92590000	usd
CY2022Q3	lcid	Accrued Unbilled Inventory Purchases AccruedUnbilledInventoryPurchases	173889000	usd
CY2021Q4	lcid	Accrued Unbilled Inventory Purchases AccruedUnbilledInventoryPurchases	12225000	usd
CY2022Q3	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	11578000	usd
CY2021Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	15796000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	33643000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	13944000	usd
CY2022Q3	lcid	Tooling Liability Current ToolingLiabilityCurrent	13708000	usd
CY2021Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	23966000	usd
CY2022Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	2141000	usd
CY2021Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	15281000	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	13575000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7815000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	usd
CY2022Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	189730000	usd
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	99404000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	686555000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	239173000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	usd
CY2022Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	125836000	usd
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3252000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	365009000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8311000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1282000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	3501000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	5256000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	8815000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	17599000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13625000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13625000	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	5700000	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2082767000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2078045000	usd
CY2022Q3	lcid	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	522262000	usd
CY2022Q3	lcid	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	513735000	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	2605029000	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	2591780000	usd
	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454500000	usd
CY2021Q2	us-gaap	Share Price SharePrice	23.78
CY2017Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1546799	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000000	usd
CY2021Q1	lcid	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	12900000	usd
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q3	lcid	Number Of Milestone Conditions Required To Receive Funding NumberOfMilestoneConditionsRequiredToReceiveFunding	2	condition
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1316758889	shares
CY2021Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1155909398	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	lcid	Common Stock Voting Rights Number Of Votes Allowed For Each Share CommonStockVotingRightsNumberOfVotesAllowedForEachShare	1	vote
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	41034197	shares
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised In Noncash Transaction ClassOfWarrantOrRightNumberOfWarrantsExercisedInNoncashTransaction	25966976	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173300000	usd
CY2021	lcid	Class Of Warrant Or Right Warrants Redeemed Or Called During Period Shares ClassOfWarrantOrRightWarrantsRedeemedOrCalledDuringPeriodShares	365803	shares
CY2021Q4	lcid	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	857825	shares
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	24.15
CY2021Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	194894204	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	210204258	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Contingency Period ReverseRecapitalizationContingentConsiderationContingencyPeriod	P5Y
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdTradingDays	40	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdConsecutiveTradingDays	60	day
CY2021	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M26D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	64119902	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2370666000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	18698664	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2289081	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.71
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	43132157	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M8D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	554954000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	31474979	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.97
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	410294000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	48234611	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	16225356	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	22935792	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	2133132	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	39391043	shares
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	83302000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	236956000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	352245000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	366200000	usd
CY2022Q3	lcid	Proceeds From Failed Sale Leaseback Transaction ProceedsFromFailedSaleLeasebackTransaction	31700000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	211844000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7815000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	239173000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	246988000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196379000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	88751000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	88751000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9780000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	79371000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	89151000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10266000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	11888000	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	8261000	usd
	lcid	Finance Lease Cost FinanceLeaseCost	2360000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	14908000	usd
	lcid	Finance Lease Cost FinanceLeaseCost	4632000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	32215000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	21811000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	906000	usd
CY2021Q3	us-gaap	Variable Lease Cost VariableLeaseCost	595000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	2581000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1754000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1217000	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	800000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3446000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2032000	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	897000	usd
CY2021Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	115000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1186000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	328000	usd
CY2022Q3	lcid	Finance Lease Cost FinanceLeaseCost	2114000	usd
CY2021Q3	lcid	Finance Lease Cost FinanceLeaseCost	915000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	9771000	usd
	us-gaap	Lease Cost LeaseCost	39428000	usd
	us-gaap	Lease Cost LeaseCost	25925000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1045
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1098
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0567
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0558
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5996000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1292000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	40795000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	9941000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	51915000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	7344000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	51301000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	5825000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	47862000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	82440000	usd
CY2022Q3	lcid	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	181496000	usd
CY2022Q3	lcid	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	114000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	379365000	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	106956000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	132377000	usd
CY2022Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	17805000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	246988000	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	89151000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7815000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9780000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	239173000	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	79371000	usd
CY2022Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	37551000	usd
CY2022Q3	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	193238000	usd
CY2022Q3	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	58939000	usd
CY2022Q3	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	1451000	usd
CY2022Q3	us-gaap	Purchase Obligation PurchaseObligation	291179000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1534081000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-530101000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-524403000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-831812000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-530101000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-524403000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-831812000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3701413000	usd
CY2022Q3	us-gaap	Dilutive Securities DilutiveSecurities	-140146000	usd
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	-998319000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-670247000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-524403000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1830131000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3701413000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1676048504	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1217032285	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1666693217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	432654607	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	14915044	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	19883372	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1690963548	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1217032285	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1686576589	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	432654607	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.56
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.56
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	122239268	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	137984401	shares
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2021Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2022Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd

Files In Submission

Name	View Source	Status
R31.htm	Edgar Link	pending
0001628280-22-028925-index-headers.html	Edgar Link	pending
0001628280-22-028925-index.html	Edgar Link	pending
0001628280-22-028925.txt	Edgar Link	pending
0001628280-22-028925-xbrl.zip	Edgar Link	pending
adrienneelenecox.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lcid-20220930.htm	Edgar Link	pending
lcid-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q32210q-ex101.htm	Edgar Link	pending
q32210q-ex311.htm	Edgar Link	pending
q32210q-ex312.htm	Edgar Link	pending
q32210q-ex321.htm	Edgar Link	pending
q32210q-ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lcid-20220930_cal.xml	Edgar Link	unprocessable
lcid-20220930_def.xml	Edgar Link	unprocessable
lcid-20220930_lab.xml	Edgar Link	unprocessable
lcid-20220930_pre.xml	Edgar Link	unprocessable
lcid-20220930_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tanyamartinez.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LCID
Lucid Group, Inc. Stock $lcid

2022 Q4 Form 10-Q Financial Statement

#000162828022028925 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID Lucid Group, Inc. Stock $lcid

2022 Q4 Form 10-Q Financial Statement

#000162828022028925 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID
Lucid Group, Inc. Stock $lcid